Journal
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
Volume 1832, Issue 10, Pages 1613-1623Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.bbadis.2013.05.005
Keywords
IncRNA; GA55; Prostate; Cancer; Apoptosis; Drug resistance
Funding
- NCRI Prostate Cancer Collaborative
- Breast Cancer Campaign and Leukaemia and Lymphoma Research
Ask authors/readers for more resources
While the role of small non-coding RNAs, such as miRNAs, in apoptosis control is well established, long non-coding RNAs (IncRNAs) have received less attention. Growth Arrest-Specific 5 (GASS) encodes multiple snoRNAs within its introns, while exonic sequences produce IncRNA which can act as a riborepressor of the glucocorticoid and related receptors. GAS5 negatively regulates the survival of lymphoid and breast cells, and is aberrantly expressed in several cancers. Although cellular GAS5 levels decline as prostate cancer cells acquire castration-resistance, the influence of GAS5 on prostate cell survival has not been determined. To address this question, prostate cell lines were transfected with GAS5-encoding plasmids or GAS5 siRNAs, and cell survival was assessed. Basal apoptosis increased, and cell survival decreased, after transfection of 22Rv1 cells with plasmids encoding GAS5 transcripts, including mature GAS5 IncRNA. Similar effects were observed in PC-3 cells. In stable clones of 22Rv1, cell death correlated strongly with cellular GAS5 levels. Induction of 22Rv1 cell death by UV-C irradiation and chemotherapeutic drugs was augmented in cells transiently transfected with GAS5 constructs, and attenuated following down-regulation of GAS5 expression. Again, in these experiments, cell death was strongly correlated with cellular GAS5 levels. Thus. GASS promotes the apoptosis of prostate cells, and exonic sequence, i.e. GAS5 IncRNA, is sufficient to mediate this activity. Abnormally low levels of GAS5 expression may therefore reduce the effectiveness of chemotherapeutic agents. Although several IncRNAs have recently been shown to control cell survival, this is the first report of a death-promoting IncRNA in prostate cells. (C) 2013 Elsevier BM. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available